GSK COREG Pill — WHITE CAPSULE, 22mm — Carvedilol

GSK pill photo
View full Carvedilol profile
ImprintGSK / COREG
ColourWHITE
ShapeCAPSULE
Size22
StrengthCARVEDILOL PHOSPHATE 80 mg
Dosage formCapsule, Extended Release
ManufacturerGlaxoSmithKline LLC
NDC0007-3373
Schedule—
Availability—
IngredientsCARVEDILOL PHOSPHATE[CARVEDILOL]

What does this imprint mean?

The imprint "GSK COREG" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Carvedilol

Uses and warnings

No boxed warning. Carvedilol is contraindicated in "bronchial asthma or related bronchospastic conditions," "second- or third-degree AV block," "sick sinus syndrome" (without a pacemaker), "severe bradycardia," cardiogenic shock or decompensated heart failure requiring IV inotropic therapy, and "severe hepatic impairment." The label warns against abrupt discontinuation, which can lead to exacerbation of angina, and advises monitoring for worsening heart failure, hypotension (especially with the first dose), and bradycardia, particularly during dose titration.

Carvedilol tablets are indicated for the treatment of: - "Mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin," usually in addition to diuretics, ACE inhibitors, and digitalis - "Left ventricular dysfunction following myocardial infarction" in clinically stable patients with an ejection fraction ≤40% - "Management of essential hypertension," used alone or in combination with other antihypertensive agents

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Carvedilol

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 23351329-9cc0-4d49-baaf-41e2a85d020f.xml